Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
The Journal of Biological Chemistry|April 24, 2009
Meningioma 1 is required for appropriate osteoblast proliferation, motility, differentiation, and functionXiaoxue Zhang, Diane R Dowd, Meika C Moore, et al.
The Journal of Investigative Dermatology|June 17, 2006
High frequency of FGFR3 mutations in adenoid seborrheic keratosesChristian Hafner, Johanna M M van Oers, Arndt Hartmann, et al.
The Journal of Clinical Investigation|July 15, 2006
Mosaicism of activating FGFR3 mutations in human skin causes epidermal neviChristian Hafner, Johanna M M van Oers, Thomas Vogt, et al.
European Urology Oncology|September 11, 2022
A Urine-based Genomic Assay Improves Risk Stratification for Patients with High-risk Hematuria Stratified According to the American Urological Association GuidelinesJoep J de Jong, Olga M Pijpers, Kim E M van Kessel, et al.
Melanoma Research|June 5, 2004
The RAS-BRAF kinase pathway is not involved in uveal melanomaEmine Kiliç, Hennie T Brüggenwirth, Michael M P J Verbiest, et al.
The Journal of Urology|February 2, 2013
Hypermethylation of the polycomb group target gene PCDH7 in bladder tumors from patients of all agesWillemien Beukers, Aleksander Hercegovac, Marcel Vermeij, et al.
European Urology|January 31, 2012
Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markersRaju Kandimalla, Angela A G van Tilborg, Lucie C Kompier, et al.
The Journal of Urology|November 17, 2009
Cystoscopy revisited as the gold standard for detecting bladder cancer recurrence: diagnostic review bias in the randomized, prospective CEFUB trialMadelon N M van der Aa, Ewout W Steyerberg, Chris Bangma, et al.
European Urology|July 1, 2008
FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumoursJohanna M M van Oers, Ellen C Zwarthoff, Ishtiaq Rehman, et al.
Plos One|November 13, 2010
FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapyLucie C Kompier, Irene Lurkin, Madelon N M van der Aa, et al.
Pageof 12